REVIEW ARTICLE
Epidemiology and natural history of atrial fibrillation: clinical implications
Sumeet S. Chugh, MD, FACC*,
Joseph L. Blackshear, MD, FACC ,
Win-Kuang Shen, MD, FACC*,
Stephen C. Hammill, MD, FACC* and
Bernard J. Gersh, MB, DPhil, ChB, FACC*
* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Division of Cardiovascular Diseases, Mayo Clinic Jacksonville, Jacksonville, Florida, USA
Manuscript received March 29, 2000;
revised manuscript received August 24, 2000,
accepted October 4, 2000.
Reprint requests and correspondence: Dr. Bernard J. Gersh, Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55905
With a substantial impact on morbidity and mortality, the growing "epidemic" of atrial fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism, hemorrhage, hypertension and left ventricular dysfunction. Currently, the epidemiology and natural history of AF govern all aspects of its clinical management. The ongoing global investigative efforts toward understanding AF are also driven by epidemiologic findings. New developments, by affecting the natural history of the disease, could eventually alter the nature of decision making in patients with AF. The crucial issue of rate versus rhythm control awaits completion of the AF Follow-up Investigation of Rhythm Management trial. The processes of electrical and structural remodeling that perpetuate AF appear to be reversible. In the era of functional genomics, the molecular basis of this ubiquitous arrhythmia is in the process of being defined. Unraveling the molecular genetics of AF might provide new insights into the structural and electrical phenotypes resulting from genetic mutations and, as such, new approaches to treatment of this arrhythmia at the ion channel and cellular levels. Thus, current adverse trends are superimposed on a background of a rapidly developing knowledge base and potentially exciting new therapeutic options. Consequently, an understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.
|
Abbreviations and Acronyms
| | AF | = atrial fibrillation | | CHF | = congestive heart failure | | LV | = left ventricle, left ventricular | | SOLVD | = Studies Of Left Ventricular Dysfunction | | SPAF | = Stroke Prevention in Atrial Fibrillation trial |
|
This article has been cited by other articles:
|
|
|
|
 
K. K. Patton, P. T. Ellinor, S. R. Heckbert, R. H. Christenson, C. DeFilippi, J. S. Gottdiener, and R. A. Kronmal
N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study
Circulation,
November 3, 2009;
120(18):
1768 - 1774.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C B De Vos, B Weijs, H J G M Crijns, E C Cheriex, A Palmans, J Habets, M H Prins, R Pisters, R Nieuwlaat, and R G Tieleman
Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation
Heart,
May 1, 2009;
95(10):
835 - 840.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Fatema, M. E. Barnes, K. R. Bailey, W. P. Abhayaratna, S. Cha, J. B. Seward, and T. S.M. Tsang
Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study
Eur J Echocardiogr,
March 1, 2009;
10(2):
282 - 286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Li, V. Timofeyev, D. Tuteja, D. Xu, L. Lu, Q. Zhang, Z. Zhang, A. Singapuri, T. R. Albert, A. V. Rajagopal, et al.
Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation
J. Physiol.,
March 1, 2009;
587(5):
1087 - 1100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Wan, C. Heneghan, R. Perera, N. Roberts, J. Hollowell, P. Glasziou, C. Bankhead, and Y. Xu
Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review
Circ Cardiovasc Qual Outcomes,
November 1, 2008;
1(2):
84 - 91.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Groh, O. A. Binns, H. G. Burton III, G. L. Champsaur, S. W. Ely, and A. M. Johnson
Epicardial Ultrasonic Ablation of Atrial Fibrillation During Concomitant Cardiac Surgery Is a Valid Option in Patients With Ischemic Heart Disease
Circulation,
September 30, 2008;
118(14_suppl_1):
S78 - S82.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Baranchuk, C. S. Simpson, D. P. Redfearn, and M. Fitzpatrick
It's time to wake up!: sleep apnea and cardiac arrhythmias
Europace,
June 1, 2008;
10(6):
666 - 667.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. Wysokinski, R. D. McBane, P. R. Daniels, S. C. Litin, D. O. Hodge, N. F. Dowling, and J. A. Heit
Periprocedural Anticoagulation Management of Patients With Nonvalvular Atrial Fibrillation
Mayo Clin. Proc.,
June 1, 2008;
83(6):
639 - 645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Y H Lip and C J Boos
Antithrombotic treatment in atrial fibrillation
Postgrad. Med. J.,
May 1, 2008;
84(991):
252 - 258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. B. de Vos, R. Nieuwlaat, H. J.G.M. Crijns, A. J. Camm, J.-Y. LeHeuzey, C. J. Kirchhof, A. Capucci, G. Breithardt, P. E. Vardas, R. Pisters, et al.
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey
Eur. Heart J.,
March 1, 2008;
29(5):
632 - 639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. K. Voeller, R. B. Schuessler, and R. J. Damiano Jr.
Surgical Treatment of Atrial Fibrillation
Card. Surg. Adult,
January 1, 2008;
3(2008):
1375 - 1394.
[Full Text]
|
|
|
|
|
|
|
D. A. Lane and G. Y.H. Lip
Barriers to Anticoagulation in Patients With Atrial Fibrillation: Changing Physician-Related Factors
Stroke,
January 1, 2008;
39(1):
7 - 9.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, R. C. Petersen, S. S. Cha, K. R. Bailey, B. J. Gersh, G. Casaclang-Verzosa, W. P. Abhayaratna, J. B. Seward, T. Iwasaka, et al.
Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort
Eur. Heart J.,
August 2, 2007;
28(16):
1962 - 1967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Frost
Lone Atrial Fibrillation: Good, Bad, or Ugly?
Circulation,
June 19, 2007;
115(24):
3040 - 3041.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Jahangir, V. Lee, P. A. Friedman, J. M. Trusty, D. O. Hodge, S. L. Kopecky, D. L. Packer, S. C. Hammill, W.-K. Shen, and B. J. Gersh
Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study
Circulation,
June 19, 2007;
115(24):
3050 - 3056.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kotoh, K. Fukahara, T. Doi, S. Nagura, and T. Misaki
Predictors of Early Postoperative Cerebral Infarction After Isolated Off-Pump Coronary Artery Bypass Grafting
Ann. Thorac. Surg.,
May 1, 2007;
83(5):
1679 - 1683.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, K. R. Bailey, S. S. Cha, B. J. Gersh, J. B. Seward, and T. S.M. Tsang
Mortality Trends in Patients Diagnosed With First Atrial Fibrillation: A 21-Year Community-Based Study
J. Am. Coll. Cardiol.,
March 6, 2007;
49(9):
986 - 992.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C.M. Choisy, L. A. Arberry, J. C. Hancox, and A. F. James
Increased Susceptibility to Atrial Tachyarrhythmia in Spontaneously Hypertensive Rat Hearts
Hypertension,
March 1, 2007;
49(3):
498 - 505.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Decher, P. Kumar, T. Gonzalez, B. Pirard, and M. C. Sanguinetti
Binding Site of a Novel Kv1.5 Blocker: A "Foot in the Door" against Atrial Fibrillation
Mol. Pharmacol.,
October 1, 2006;
70(4):
1204 - 1211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Lombardi, M. Borggrefe, W. Ruzyllo, B. Luderitz, and for the A-COMET-II Investigators
Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial
Eur. Heart J.,
September 2, 2006;
27(18):
2224 - 2231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Scanavacca, C. F. Pisani, D. Hachul, S. Lara, C. Hardy, F. Darrieux, I. Trombetta, C. E. Negrao, and E. Sosa
Selective Atrial Vagal Denervation Guided by Evoked Vagal Reflex to Treat Patients With Paroxysmal Atrial Fibrillation
Circulation,
August 29, 2006;
114(9):
876 - 885.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Olson, A. E. Alekseev, X. K. Liu, S. Park, L. V. Zingman, M. Bienengraeber, S. Sattiraju, J. D. Ballew, A. Jahangir, and A. Terzic
Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation
Hum. Mol. Genet.,
July 15, 2006;
15(14):
2185 - 2191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, K. R. Bailey, W. P. Abhayaratna, J. B. Seward, and T. S.M. Tsang
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
Circulation,
July 11, 2006;
114(2):
119 - 125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Jahangiri, G. Weir, K. Mandal, I. Savelieva, and J. Camm
Current strategies in the management of atrial fibrillation.
Ann. Thorac. Surg.,
July 1, 2006;
82(1):
357 - 364.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. van der Hooft, J. Heeringa, G. G. Brusselle, A. Hofman, J. C. M. Witteman, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. Ch. Stricker
Corticosteroids and the risk of atrial fibrillation.
Arch Intern Med,
May 8, 2006;
166(9):
1016 - 1020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P Korantzopoulos, T M Kolettis, A Papathanasiou, K K Naka, P Kolios, I Leontaridis, A Draganigos, C S Katsouras, and J A Goudevenos
Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation
Heart,
May 1, 2006;
92(5):
631 - 634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, K. R. Bailey, W. Abhayaratna, J. B. Seward, T. Iwasaka, and T. S.M. Tsang
Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades
Eur. Heart J.,
April 2, 2006;
27(8):
936 - 941.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. O. Arnar, S. Thorvaldsson, T. A. Manolio, G. Thorgeirsson, K. Kristjansson, H. Hakonarson, and K. Stefansson
Familial aggregation of atrial fibrillation in Iceland
Eur. Heart J.,
March 2, 2006;
27(6):
708 - 712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Y H Lip and C J Boos
Antithrombotic treatment in atrial fibrillation
Heart,
February 1, 2006;
92(2):
155 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T. Ellinor, A. F. Low, and C. A. MacRae
Reduced apelin levels in lone atrial fibrillation
Eur. Heart J.,
January 2, 2006;
27(2):
222 - 226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Zhang, Y. He, D. Tuteja, D. Xu, V. Timofeyev, Q. Zhang, K. A. Glatter, Y. Xu, H.-S. Shin, R. Low, et al.
Functional Roles of Cav1.3({alpha}1D) Calcium Channels in Atria: Insights Gained From Gene-Targeted Null Mutant Mice
Circulation,
September 27, 2005;
112(13):
1936 - 1944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Dixon, Y. Bracha, S. W. Loecke, M. A. Guerrero, R. D. Taylor, and R. W. Asinger
Principal Atrial Fibrillation Discharges by the New ACC/AHA/ESC Classification
Arch Intern Med,
September 12, 2005;
165(16):
1877 - 1881.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Healey, A. Baranchuk, E. Crystal, C. A. Morillo, M. Garfinkle, S. Yusuf, and S. J. Connolly
Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis
J. Am. Coll. Cardiol.,
June 7, 2005;
45(11):
1832 - 1839.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Gersh, T. S.M. Tsang, M. E. Barnes, and J. B. Seward
The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors
Eur. Heart J. Suppl.,
May 1, 2005;
7(suppl_C):
C5 - C11.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Vest, X. H.T. Wehrens, S. R. Reiken, S. E. Lehnart, D. Dobrev, P. Chandra, P. Danilo, U. Ravens, M. R. Rosen, and A. R. Marks
Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation
Circulation,
April 26, 2005;
111(16):
2025 - 2032.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T. Ellinor, A. F. Low, K. K. Patton, M. A. Shea, and C. A. MacRae
Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
82 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. van der Hooft, J. Heeringa, G. van Herpen, J. A. Kors, J. H. Kingma, and B. H. Ch. Stricker
Drug-induced atrial fibrillation
J. Am. Coll. Cardiol.,
December 7, 2004;
44(11):
2117 - 2124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P T Ellinor, R K Moore, K K Patton, J N Ruskin, M R Pollak, and C A MacRae
Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation
Heart,
December 1, 2004;
90(12):
1487 - 1488.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. L. L'Allier, A. Ducharme, P.-F. Keller, H. Yu, M.-C. Guertin, and J.-C. Tardif
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation
J. Am. Coll. Cardiol.,
July 7, 2004;
44(1):
159 - 164.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Romano, D. S. Bach, F. D. Pagani, R. L. Prager, G. M. Deeb, and S. F. Bolling
Atrial reduction plasty Cox maze procedure: extended indications for atrial fibrillation surgery
Ann. Thorac. Surg.,
April 1, 2004;
77(4):
1282 - 1287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Stewart, N Murphy, A Walker, A McGuire, and J J V McMurray
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
Heart,
March 1, 2004;
90(3):
286 - 292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Djaiani, B. Phillips-Bute, M. Podgoreanu, R. H. Messier, J. P. Mathew, F. Clements, and M. F. Newman
The Association of Patent Foramen Ovale and Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
Anesth. Analg.,
March 1, 2004;
98(3):
585 - 589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Fang, R. S. Stafford, J. N. Ruskin, and D. E. Singer
National Trends in Antiarrhythmic and Antithrombotic Medication Use in Atrial Fibrillation
Arch Intern Med,
January 12, 2004;
164(1):
55 - 60.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Baldasseroni and A. P. Maggioni
Authors reply to the letter titled: 'Mortality in congestive heart failure complicated by atrial fibrillation'
Eur. Heart J.,
January 1, 2004;
25(1):
98 - 98.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Kristensen, J. C. Nielsen, P. T. Mortensen, A. K. Pedersen, and H. R. Andersen
Evaluation of pacemaker telemetry as a diagnostic feature for detecting atrial tachyarrhythmias in patients with sick sinus syndrome
Europace,
January 1, 2004;
6(6):
580 - 585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. R Kasliwal, S. Mukesh, G. Manohar, N. Aggarwal, and A. Bhatia
Pharmacotherapy of Atrial Fibrillation
Asian Cardiovasc Thorac Ann,
December 1, 2003;
11(4):
364 - 374.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Maurer
Age: a nonmodifiable risk factor?
J. Am. Coll. Cardiol.,
October 15, 2003;
42(8):
1427 - 1428.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A Gould, M. D Esler, and D. M Kaye
Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure
Eur. Heart J.,
September 2, 2003;
24(18):
1657 - 1662.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Likosky, B. J. Leavitt, C. A. S. Marrin, D. J. Malenka, A. G. Reeves, R. M. Weintraub, L. R. Caplan, Y. R. Baribeau, D. C. Charlesworth, C. S. Ross, et al.
Intra- and postoperative predictors of stroke after coronary artery bypass grafting
Ann. Thorac. Surg.,
August 1, 2003;
76(2):
428 - 434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Mestroni
Genomic medicine and atrial fibrillation
J. Am. Coll. Cardiol.,
June 18, 2003;
41(12):
2193 - 2196.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T. Ellinor, J. T. Shin, R. K. Moore, D. M. Yoerger, and C. A. MacRae
Locus for Atrial Fibrillation Maps to Chromosome 6q14-16
Circulation,
June 17, 2003;
107(23):
2880 - 2883.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Essebag, T. Hadjis, R. W. Platt, and L. Pilote
Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction
J. Am. Coll. Cardiol.,
January 15, 2003;
41(2):
249 - 254.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-H. Chen, S.-J. Xu, S. Bendahhou, X.-L. Wang, Y. Wang, W.-Y. Xu, H.-W. Jin, H. Sun, X.-Y. Su, Q.-N. Zhuang, et al.
KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation
Science,
January 10, 2003;
299(5604):
251 - 254.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Gorenek, G. Kudaiberdieva, O. Goktekin, Y. Cavusoglu, A. Birdane, A. Unalir, N. Ata, and B. Timuralp
Long-short sequence may predict immediate recurrence of atrial fibrillation after external cardioversion
Europace,
January 1, 2003;
5(1):
11 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. S. M. Tsang, B. J. Gersh, C. P. Appleton, A. J. Tajik, M. E. Barnes, K. R. Bailey, J. K. Oh, C. Leibson, S. C. Montgomery, and J. B. Seward
Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women
J. Am. Coll. Cardiol.,
November 6, 2002;
40(9):
1636 - 1644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Williams, N. Hu, W. Shen, A. B. Mashburn, and K. T. Murray
Modulation of the Human Kv1.5 Channel by Protein Kinase C Activation: Role of the Kvbeta 1.2 Subunit
J. Pharmacol. Exp. Ther.,
August 1, 2002;
302(2):
545 - 550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Stein, D. E. Euler, R. Mehra, K. Seidl, D. J. Slotwiner, S. Mittal, S. M. Markowitz, B. B. Lerman, and Jewel AF Worldwide Investigators
Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?
J. Am. Coll. Cardiol.,
July 17, 2002;
40(2):
335 - 340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. MARBAN, H.B. NUSS, and J.K. DONAHUE
Gene Therapy for Cardiac Arrhythmias
Cold Spring Harb Symp Quant Biol,
January 1, 2002;
67(0):
527 - 532.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Palinkas, E. Antonielli, E. Picano, A. Pizzuti, A. Varga, B. Nyuzo, J.M. Alegret, A. Bonzano, M. Tanga, A. Coppolino, et al.
Clinical value of left atrial appendage flow velocity for predicting of cardioversion success in patients with non-valvular atrial fibrillation
Eur. Heart J.,
December 1, 2001;
22(23):
2201 - 2208.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Arndt, U. Lendeckel, C. Rocken, K. Nepple, C. Wolke, A. Spiess, C. Huth, S. Ansorge, H. U. Klein, and A. Goette
Altered Expression of ADAMs (A Disintegrin And Metalloproteinase) in Fibrillating Human Atria
Circulation,
February 12, 2002;
105(6):
720 - 725.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Xu, H.-F. Tse, F. H.Y. Chan, P. C. W. Fung, K. L.-F. Lee, and C.-P. Lau
New Bayesian Discriminator for Detection of Atrial Tachyarrhythmias
Circulation,
March 26, 2002;
105(12):
1472 - 1479.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
